{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00304",
      "entity_text" : "ER glucose-6-phosphatase",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P15516",
      "entity_text" : "PB",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "PB treatment reduces the activity of ER glucose-6-phosphatase [XREF_BIBR] which is responsible for hepatic glucose production from glycogen breakdown or gluconeogenesis, and induces glucokinase [XREF_BIBR], the major enzyme in the hepatic utilization of glucose.",
  "reading_complete" : "2020-07-28T14:03:43Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T13:54:14Z",
  "trigger" : "reduces",
  "evidence" : [ "PB treatment reduces the activity of ER glucose-6-phosphatase" ],
  "pmc_id" : "3282906",
  "score" : 0
}